Please login to the form below

Meet OPEN Health and Pharmerit Experts at the World Pharma Pricing Market Access and Evidence Congress 2020

Join OPEN Health and Pharmerit – an OPEN Health Company at the World Pharma Pricing Market Access and Evidence Congress from 23 – 25 September 2020, as we present:

ROUNDTABLE: Wednesday, September 23, 13:00 
Exploring Digital Therapeutics

Moderated by: Olaf Schoeman, MSc, Director and German Lead

Presentation: Thursday, September 24, 14:30
EUnetHTA Joint Assessments and Implications for the Industry

Rosemary Jose, PhD, Director and Commercial Lead, Strategic Market Access

We welcome you to schedule a meeting with one of our team members Rosemary JoseOlaf Schoeman, Marja HensenWalter BouwmeesterAndrew Revel, Marie Keetley or Phil Drew to discuss your market access, HEOR and real-world evidence needs.

OPEN Health is a family of expert practices working in partnership to drive positive change in healthcare communications and market access globally. It all started with a vision to create a new, unique entity equipped to be a global leader in HEOR, market access, medical and patient brand communications and digital services. By bringing together the Pharmerit and OPEN VIE teams to create the Evidence and Access practice, we have expanded our global footprint and capabilities in HEOR and market access. This newly integrated team provides world-class knowledge, insight and outputs across the entire spectrum of market access and reimbursement, evidence generation, gathering and evaluation, and population-based health data. Our multidisciplinary teams work across four centers of excellence:

Together, we have grown to over 700 people in 15 offices across 6 different countries including US, UK, The Netherlands, Germany, India and China. What makes us different is our deeply integrated teams working collaboratively to bring the strategic and technical expertise needed to be a solid partner to our sponsors. Combine this with our broad scope of therapeutic expertise to produce results and solutions that are of the highest quality. We pride ourselves on having a highly skilled, diverse, and connected team working across the globe to deliver truly innovative and best-in-class solutions. This has resulted in long-term, flexible partnerships that span many years across multiple brands and therapy areas.

Pink divider

For more information on how we are improving the lives of patients, worldwide, please visit www.openhealthgroup.com

10th September 2020

Share

Company Details

OPEN Health

+44 1628 481112

Contact Website

Address:
The Weighbridge
Brewery Courtyard
High Street
Marlow
Buckinghamshire
SL7 2FF
United Kingdom

Latest content on this profile

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health
OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health
OPEN Health
OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member
OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.
OPEN Health
Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access
OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.
OPEN Health
OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital
OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical communications platform from NaviMed Capital (“NaviMed”).
OPEN Health
How digital health is changing the relationship between patients and health providers | OPEN Health
The pandemic has forced pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes
OPEN Health
David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access
David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access
OPEN Health